About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Lupus
›
top-articles
Lupus
2.0
(top 20%)
impact factor
5.7K
(top 5%)
papers
156.7K
(top 5%)
citations
121
(top 5%)
h
-index
2.1
(top 20%)
impact factor
6.4K
all documents
164.2K
doc citations
171
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines
Lupus
2003
757
2
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden
Lupus
2006
665
3
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies
Lupus
2011
467
4
Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus
Lupus
2000
438
5
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
Lupus
2000
402
6
Mechanisms of action of mycophenolate mofetil
Lupus
2005
366
7
Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
Lupus
2001
364
8
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
Lupus
2006
351
9
Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity
Lupus
2004
335
10
Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients
Lupus
2007
335
11
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis
Lupus
2002
315
12
Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII)
Lupus
2008
312
13
Cardiac involvement in systemic lupus erythematosus
Lupus
2005
305
14
Systemic lupus erythematosus in three ethnic groups: III A comparison of characteristics early in the natural history of the LUMINA cohort
Lupus
1999
291
15
Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies
Lupus
2013
274
16
Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases
Lupus
2009
273
17
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity
Lupus
1995
267
18
A Phospholipid-β2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with Infection
Lupus
1992
265
19
The innate immune system in SLE: type I interferons and dendritic cells
Lupus
2008
262
20
Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—A meta-analysis
Lupus
1997
259
21
Review: Neuropsychiatric involvement in pediatric systemic lupus erythematosus
Lupus
2007
259
22
Rationale for interleukin-6 blockade in systemic lupus erythematosus
Lupus
2004
253
23
A Long-Term Study of Hydroxychloroquine Withdrawal on Exacerbations in Systemic Lupus Erythematosus
Lupus
1998
250
24
Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
Lupus
2013
246
25
Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus
Lupus
2001
244
26
Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies
Lupus
1997
241
27
Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study
Lupus
2006
231
28
Adjuvants and autoimmunity
Lupus
2009
228
29
A review of health related quality of life in systemic lupus erythematosus
Lupus
2006
226
30
Classification and definition of major flares in SLE clinical trials
Lupus
1999
220
31
Vasculitis in systemic lupus erythematosus
Lupus
1997
217
32
Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis
Lupus
2016
214
33
Presence of cutaneous interferon-a producing cells in patients with systemic lupus erythematosus
Lupus
2001
209
34
Validation of a systemic lupus activity questionnaire (SLAQ) for population studies
Lupus
2003
209
35
The nature and outcome of infection in systemic lupus erythematosus
Lupus
2002
205
36
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis
Lupus
1996
202
37
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients
Lupus
1998
201
38
The interferon-α signature of systemic lupus erythematosus
Lupus
2010
201
39
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Lupus
2006
199
40
Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort
Lupus
2000
197
41
High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus
Lupus
1998
194
42
Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual
Lupus
2007
189
43
Apoptosis in the pathogenesis of systemic lupus erythematosus
Lupus
2008
189
44
Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States
Lupus
2002
187
45
Prognostic determinants in lupus nephritis: a long-term clinicopathologic study
Lupus
1995
186
46
Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis
Lupus
1998
186
47
Ethnic and geographical differences in systemic lupus erythematosus: an overview
Lupus
2006
186
48
Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy
Lupus
2000
185
49
The blood-brain barrier in systemic lupus erythematosus
Lupus
2003
185
50
Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions
Lupus
2010
185
site/software ©
exaly
; All materials licenced under
CC by-SA
.